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Retinitis pigmentosa (RP) and age-related macular
degeneration (AMD) are degenerative blinding
diseases caused by the death of rods and cones,
leaving the remainder of the visual system intact
but largely unable to respond to light. Here, we
show that AAQ, a synthetic small molecule photo-
switch, can restore light sensitivity to the retina and
behavioral responses in vivo in mouse models of
RP, without exogenous gene delivery. Brief applica-
tion of AAQ bestows prolonged light sensitivity on
multiple types of retinal neurons, resulting in synapti-
cally amplified responses and center-surround
antagonism in arrays of retinal ganglion cells
(RGCs). Intraocular injection of AAQ restores the
pupillary light reflex and locomotory light avoidance
behavior in mice lacking retinal photoreceptors, indi-
cating reconstitution of light signaling to brain
circuits. AAQ and related photoswitch molecules
present a potential drug strategy for restoring retinal
function in degenerative blinding diseases.
INTRODUCTION
Inherited degenerative diseases of the retina including retinitis
pigmentosa (RP) affect 1 in 3,000 people worldwide. As differen-
tiation of rods and cones ceases soon after birth in mammals,
disorders resulting in photoreceptor degeneration lead to
a permanent visual deficit. At present, there is no effective treat-
ment for preventing this degenerative process and without some
means of restoring photoreception, patients with advanced RP
face the prospect of irreversible blindness.
Retinal ganglion cells (RGCs) are the sole output neurons of
the retina. Hence, all of the visual information that reaches the
brain is encoded by the spatial and temporal pattern of RGC
action potentials. Several strategies have been advanced toenable light to alter RGC firing in the absence of rods and cones,
with the goal of restoring visual function after the photoreceptors
are lost (Jime´nez et al., 1996; Marc et al., 2003; Punzo and
Cepko, 2007; Strettoi and Pignatelli, 2000). First, biomedical
engineers have developed surgically implanted retinal ‘‘chip’’
prosthetics (Chader et al., 2009; Gerding et al., 2007; Shire
et al., 2009) that can be electronically controlled by an external
camera to enable optical stimuli to trigger RGC firing. Retinal
implants have restored simple shape discrimination to blind
patients (Humayun et al., 2003; Yanai et al., 2007), indicating
that artificial stimulation of RGCs in vivo can create a useful
visual experience. Second, genes encoding optogenetic tools,
including light-activated ion channels (Bi et al., 2006; Lagali
et al., 2008; Tomita et al., 2010), transporters (Busskamp et al.,
2010), or receptors (Caporale et al., 2011; Lin et al., 2008), can
be introduced with viruses to bestow light-sensitivity on retinal
neurons that survive after the natural photoreceptive cells have
degenerated. Expression of optogenetic proteins in RGCs
(Caporale et al., 2011; Tomita et al., 2010), bipolar cells (Lagali
et al., 2008), and remnant cones (Busskamp et al., 2010) can
reinstate light-elicited behavioral responses in mouse models
of RP. Third, embryonic stem cells can be differentiated into
photoreceptor progenitors in vitro (Lamba et al., 2006). Injecting
these progenitors into blind animals results in integration of
photoreceptors in the retina and restoration of some electrical
activity in response to light (Lamba et al., 2009).
Each of these strategies has shown promise for restoring
visual function, but they all require highly invasive and/or irre-
versible interventions that introduce hurdles to further develop-
ment as a therapeutic approach. Implantation of retinal chips
or stem cell-derived photoreceptors requires invasive surgery,
while exogenous expression of optogenetic tools leads to
permanent genetic alterations in retinal neurons. Retinal chip
prosthetics rely on extracellular electrical stimulation of RGCs,
which can be cytotoxic when excessive (Winter et al., 2007).
Stem cell therapies carry potential for teratoma formation
(Chaudhry et al., 2009). Viruses that deliver optogenetic tools
can have off-target effects and may elicit inflammatory
responses (Beltran et al., 2010). While the potential permanenceNeuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc. 271
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Restoration of Visual Responses in Blind Miceof optoelectronic, stem cell, or optogenetic interventions could
be favorable in the absence of complications, any deleterious
effects of these treatments could be very difficult or impossible
to reverse.
Here, we report an alternative strategy for restoring visual
function, based on a small molecule ‘‘photoswitch’’ that bestows
light sensitivity onto neurons without requiring exogenous gene
expression. The photoswitch is injected into the vitreous cavity
of the eye, but unlike the other strategies, it does not require
highly invasive surgical interventions and its actions are revers-
ible. We used acrylamide-azobenzene-quaternary ammonium
(AAQ), a K+ channel photoswitch that enables optical control of
neuronal excitability (Banghart et al., 2009; Fortin et al., 2008).
AAQ was originally thought to conjugate to K+ channels (Fortin
et al., 2008), but recent work shows that the molecule interacts
noncovalently with the cytoplasmic side of the channels, similar
to the mechanism of action of local anesthetics (Banghart et al.,
2009). The trans form of AAQ blocks K+ channels and increases
excitability, whereas photoisomerization to the cis form with
short wavelength light (e.g., 380 nm) unblocks K+ channels and
decreases excitability. Relaxation from cis to trans occurs slowly
in darkness but much more rapidly in longer-wavelength light
(e.g., 500 nm), enabling rapid bi-directional photocontrol of
neuronal firing with different wavelengths.
We show that AAQ confers robust light responses in RGCs in
retinas from mutant mice that lack rods and cones. Moreover,
after a single intraocular injection, AAQ restores light-driven
behavior in blind mice in vivo. Because it is a rapid and reversible
drug-like small molecule, AAQ represents a class of compounds
that has potential for the restoration of visual function in humans
with end-stage photoreceptor degenerative disease.
RESULTS
Imparting Light Sensitivity on rd1 Mouse Retina
with AAQ
We tested whether AAQ can impart light sensitivity on retinas
from 6-month-old rd1mice, a murine model of RP. The homozy-
gous rd1 mouse (rd1/rd1) has a mutation in the gene encoding
the b-subunit of cGMP phosphodiesterase-6, essential for rod
phototransduction. Rods and cones in these mice degenerate
nearly completely within 3 months after birth, leading to a loss
of electrical and behavioral light responses (Sancho-Pelluz
et al., 2008). We placed the rd1 mouse retina onto a multi-elec-
trode array (MEA) that enables simultaneous extracellular
recording from many RGCs (Meister et al., 1994). Before AAQ
application, light generated nomeasurable change in RGC firing.
However, after 30 min of treatment with AAQ, nearly all RGCs
responded to light (Figure 1A). Photosensitization increased
with AAQ concentration (Figure S1; Table S1 available online),
but we used 300 mM for our standard ex vivo treatment. Light
responses slowly diminished but were still robust for >5 hr after
removing AAQ from the bathing medium (Figure S2a). Light
responses could also be detected in three of four recordings
from retinas removed from rd1 mice that had received in vivo
intravitreal AAQ injections 12 hr previously (Figure S2b). The
degree of photosensitivity varied, reflecting inaccurate injection
in the small intravitreal volume of the mouse eye (2–3 ml).272 Neuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc.Most RGCs exhibited an increase in firing rate in response to
380 nm light and a decrease in 500 nm light, opposite to AAQ-
mediated light responses in neurons in culture (Fortin et al.,
2008). To quantify the effects of light, we calculated a photoswitch
index (PI), representing the normalized change in firing rate upon
switching from darkness to 380 nm light. Positive or negative PI
values reflect an increase or decrease, respectively, of firing.
Before AAQ treatment, RGCs had almost no light response
(median PI = 0.02); but after treatment, nearly all were activated
by 380 nm light (median PI = 0.42) (Figure 1B). The rare light
responses before AAQ treatment might result from melanopsin-
containing intrinsically photosensitive RGCs (ipRGCs), which
account for 3% of the RGCs in the adult mouse retina (Hattar
et al., 2002). Significant photosensitization was observed in each
of 21 AAQ-treated retinas. On average, we observed an 3-fold
increase in RGC firing rate in response to 380 nm light, with indi-
vidual retinas showing up to an 8-fold increase (Figure 1C).
AAQ Acts on RGCs, Bipolar, and Amacrine Cells
in rd1 Retinas
We were surprised that 380 nm light stimulated RGC firing
because this wavelength unblocks K+ channels, which should
reduce neuronal excitability. However, since RGCs receive
inhibitory input from amacrine cells, RGC stimulation might be
indirect, resulting from amacrine cell-dependent disinhibition.
To test this hypothesis, we applied antagonists of receptors for
GABA and glycine, the two inhibitory neurotransmitters released
by amacrine cells. Photosensitization of RGCs by AAQ persisted
after adding inhibitors of GABAA, GABAC, and glycine receptors
(Figure 2A), but the polarity of photoswitching was reversed, with
nearly all neurons inhibited rather than activated by 380 nm
light (Figure 2B). These results indicate that photoregulation of
amacrine cells is the dominant factor that governs the AAQ-
mediated light response of RGCs.
After blocking amacrine cell synaptic transmission, the re-
maining light response could result from photoregulation of K+
channels intrinsic to RGCs and/or photoregulation of excitatory
inputs from bipolar cells. To explore the contribution of intrinsic
K+ channels, we obtained whole-cell patch clamp recordings
from RGCs and pharmacologically blocked nearly all synaptic
inputs (glutamatergic, GABAergic, and glycinergic). Depolarizing
voltage steps activated outward K+ currents that were smaller
and decayed more rapidly in 500 nm light than in 380 nm light
(Figure 2C). Comparison of current versus voltage (I-V) curves
shows that the current was reduced by 50% in 500 nm light
(Figure 2D), similar to previous results (Fortin et al., 2008).
However, MEA recordings indicate that photoregulation of
RGC firing was nearly eliminated by blocking all excitatory and
inhibitory synaptic inputs (Figure S3), suggesting that the light
response is driven primarily by photoregulation of upstream
neurons synapsing with RGCs.
To examine directly the contribution of retinal bipolar cells to
the RGC light response, we blocked RGCK+ channels with intra-
cellular Cs+ and added GABA and glycine receptor antagonists
to block amacrine cell inputs. Flashes of 500 nm light triggered
excitatory postsynaptic currents (EPSCs) in RGCs, and 380 nm
light suppressed these events (Figures 2E and 2F). Blocking
glutamate receptors eliminated these events, and bipolar cells
Figure 1. AAQ Imparts Light Sensitivity onto Blind Retinas from rd1 Mice
(A) Multi-electrode recordings from a flat-mounted rd1mouse retina before and after treatment with AAQ (300 mM for 25 min, followed by washout). Top: Raster
plot of spiking from RGCs. Bottom: Average RGC firing rate calculated in 100 ms time bins. Color bars represent illumination with 380 nm (violet) or 500 nm light
(green), separated by periods of darkness (black).
(B) Analysis of photoswitching of the entire population of RGCs from all untreated retinas and all AAQ-treated retinas. Untreated retinas (n = 12) had PI values
near 0, indicating no photoswitching, AAQ-treated retinas (n = 21) had PI values >0, indicating an increase in firing frequency after switching from darkness
to 380 nm light.
(C) AAQ-mediated photosensitivity results from an increase in firing rate in 380 nm light. Average RGC firing rates in untreated retinas and AAQ-treated retinas in
darkness and during the first 5 s in 380 nm light. Note that untreated retinas (n = 12) fail to respond to light, but AAQ-treated retinas have RGCs that increase firing
rate with 380 nm light. Red symbols show median values and error bars represent 95% confidence intervals for untreated and treated retinas (p < 0.0001, Mann-
Whitney test).
See also Figures S1 and S2.
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conclude that inputs from amacrine cells, bipolar cells, and to
a lesser extent, the intrinsic K+ conductances of RGCs, all
combine to shape and amplify the AAQ-mediated RGC light
response.
Spatial Localization and Center-Surround Antagonism
of RGC Light Responses in AAQ-Treated Retina
Visual acuity is determined by the size of receptive fields of
neurons in the visual system. In the healthy retina, the receptive
field of an RGC is defined by the spatial extent of all of the photo-
receptors that influence its activity. By definition, the receptive
fields of RGCs in rd1 mice are eliminated after the photorecep-
tors have degenerated. However because AAQ makes presyn-
aptic neurons light-sensitive, it is possible to measure the spatial
extent of their light-driven influence on RGC firing. While this is
not a conventional measurement of the RGC receptive field, it
does indicate the spatial precision of the AAQ-mediated RGC
light response.We illuminated AAQ-treated retinas with small spots (60 mm
diameter) of 380 nm light centered on one of the 60 electrodes
in an MEA (Figure 3A). In the example shown in Figure 3A,
upon switching from 500 to 380 nm light, the average RGC
activity increased in the targeted electrode by 81% but not in
the surrounding electrodes. In each of a total of eight targeted
spots from three different retinas, only neurons near the targeted
electrode exhibited a significant increase in firing (median
PI = 0.517; Figure 3B). Since RGCs are detected by only one
electrode and they are spaced 200 mm apart, this puts an upper
limit on the radius of the AAQ-mediated RGC collecting area of
100 mm.
Analysis of electrodes outside the illuminated spot showed
that 380 nm light significant decreased RGC firing. Decreased
firing was detected in electrodes centered at 300, 500, and
700 mm from the mid-point of the targeted electrode (Figure 3C;
Table 1). Hence, RGCs in the center of an illuminated spot are
stimulated, whereas those in a surrounding annulus (from
200 to 800 mm) are inhibited. Inhibition in the surroundingNeuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc. 273
Figure 2. Multiple Types of Retinal Neurons
Contribute to the AAQ-Mediated Light
Response of RGCs
(A) Amacrine cell-mediated synaptic inhibition
dominates the RGC light response. MEA recording
with antagonists of GABAA (gabazine; 4 mM),
GABAC (TPMPA; 10 mM), and glycine receptors
(strychnine; 10 mM) is shown. Top: Raster plot of
RGC spiking. Bottom: Average RGC firing rate.
(B) After blocking inhibition, PI values show
a decrease in firing frequency upon switching from
darkness to 380 nm light (n = 11 retinas).
(C) Endogenous K+ channels contribute to the
RGC light response. Whole-cell patch clamp
recording from an RGC. Currents were evoked by
voltage steps from 80 to +40mV in 20mV incre-
ments in 380 nm and 500 nm light. Inhibitory
GABAergic and glycinergic inputs were blocked as
in (A), and excitatory glutamatergic inputs were
blocked with DNQX (10 mM) and AP5 (50 mM).
(D) Photoregulation of endogenous K+ channels
evaluated in steady-state I-V curves obtained in
380 and 500 nm light (n = 5 RGCs). Current is
normalized to themaximal value at +40mV (380 nm
light). Variability among data is expressed as
mean ± SEM.
(E) Bipolar cell-mediated synaptic excitation also
contributes to the RGC light response. Whole-cell
patch clamp recording from an RGC. Blockade of
inhibitory synaptic inputs (as in A) and endogenous
RGC K+ channels (as in C) reveals photoregulation
of EPSC rate. Note the disappearance of EPSCs
after perfusion with glutamate receptor antago-
nists DNQX (10 mM) and AP5 (50 mM). Holding
potential = 60mV.
(F) Average EPSC rate in 380 nm and 500 nm light. Note the significant increase in EPSC rate in 500 nm light (p < 0.05, Mann-Whitney test; n = 9 cells). Red
symbols show median values and error bars represent 95% confidence intervals.
See also Figure S3.
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jecting neuron is involved in transmitting information from the
center illuminated area to the surround. Amacrine cells are
known to form a mutually inhibitory network, making them the
likely source of the inhibitory signal.
Spectral Requirements of AAQ-Mediated Light
Responses
We determined the optimal wavelength for turning off RGC firing
when the AAQ photoswitch is driven from the cis to the trans
configuration. First, a conditioning 380 nm stimulus was used
to turn on firing and then we measured suppression of firing in
response to test flashes of different wavelengths. We found
that 500 nm light is best at suppressing activity (Figure 4A), as
expected from previous results (Fortin et al., 2008). To determine
which wavelengths are best at triggering firing when AAQ photo-
isomerizes from trans to cis, we again applied test flashes of
different wavelengths, but to ensure that the photoswitch started
maximally in the trans configuration, the stimulation protocol
began with a reset flash of 500 nm light followed by a period of
darkness. We found that the optimal wavelength for stimulating
firing was 380 nm under these conditions. However, robust firing
could also be activated with 420 or 460 nm light (Figure 4B), and
even 500 nm light could trigger an increase in firing frequency if274 Neuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc.the preceding dark interval was sufficiently long. The history
dependence of photoswitching is a consequence of the initial
ratio of the cis and trans photoisomers. Starting with all mole-
cules in the trans state, even 500 nm light can increase the frac-
tion of cismolecules. Hence, UV light is not essential for eliciting
retinal responses. We also found that broad spectrum white light
can trigger an increase in firing frequency in RGCs (Figures 4C
and 4D).
We measured the absolute light intensity required to photore-
gulate AAQ-treated retinas from rd1 mice. The threshold inten-
sity required to induce RGC firing was 2.6 3 1015 photons/
cm2/s of 380 nm light (Figure 4E). The RGC firing rate increased
progressively with brighter light, up to 1017 photons/cm 2/s, but
even this intensity did not saturate the response. By comparison,
retinas from rd1 mice expressing ChR2 in bipolar cells (Lagali
et al., 2008) have RGCs that exhibit a firing threshold of 6 3
1015 photons/cm2/s.
Restoring Behavioral Light Responses In Vivo with AAQ
Given that AAQ can bestow photosensitivity onto blind retinas
ex vivo, we asked whether it can confer light-induced behavior
in blind mice in vivo. Although rd1 mice lose all morphologically
recognizable rods and cones, a small fraction of cones with
altered morphology can survive, allowing correct performance
Figure 3. The AAQ-Treated Retina Gener-
ates Spatially Precise Light Responses
(A) Targeted illumination of a portion of the retina
centered on a single MEA electrode (top). The
target (electrode E6) was exposed to 3 s flashes of
alternating 380 and 500 nm light. Spot size =
60 mm in radius, inter-electrode spacing = 200 mm.
Only the targeted electrode records an increase in
RGC firing in response to 380 nm light (bottom).
PI values are color-coded (scale at left) and also
represented by bar height. The red bar is electrode
E6 (PI = 0.812; n = 1 cell), and blue electrodes are
the surround (PI = 0.209; n = 56 cells). Empty
squares are electrodes on which no action
potentials were recorded.
(B) Targeted illumination results from three retinas,
displayed in a box plot. PI values for the target and
the surround RGCs are significantly different from
one another (p < 0.005, Mann-Whitney test).
Whiskers denote 1.5 times the interquartile range
from the 25th and 75th percentile.
(C) Targeted illumination elicits opposite
responses in center and surround RGCs (n = 11
cells and n = 385 cells, respectively, from three
retinas). PI values of RGCs (open circles) as
a function of distance from the target electrode,
displayed in 200 mm bins. The red diamonds indi-
cate the median plus or minus the bootstrapped
95% confidence intervals. See Table 1 for values.
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(Thyagarajan et al., 2010). Rd1 mice also exhibit a pupillary light
reflex (PLR), but this behavior is completely absent from rd1mice
lacking melanopsin, the photopigment found in the small
percentage (3%) of RGCs that are intrinsically photosensitive
(ipRGCs) (Hattar et al., 2002; Panda et al., 2003). Therefore, we
tested the PLR of adult rd1 mice lacking the melanopsin gene
(opn4/ rd1/rd1) (Panda et al., 2003). After 3 months of age,
no PLR could be elicited in any of the mice that we tested,
even with the brightest light available (Figure 5A). However, in
a subset of these mice (9 out of 25), intravitreal injection of
AAQ resulted in a substantial PLR, with a maximal pupillary
constriction of65% as large as wild-type. Control experiments
showed no restoration of the PLR following sham injection of
vehicle alone (n = 4; Figure S4). The AAQ-mediated response
was attributable to the retina, as direct application of AAQ to
the isolated iris in vitro did not produce light-elicited constriction.
In the remaining mice, suboptimal intravitreal placement or
leakage resulting from puncture damage may have reduced
how much AAQ reached the retina, precluding effective
photosensitization.Table 1. Center and Surround RGC Responses under Targeted
Illumination
Distance (um) No. of Cells Median PI 95% Confidence Interval
Target 11 0.517 0.455 to 0.812
200–400 95 0.165 0.239 to 0.090
400–600 143 0.213 0.284 to 0.150
600–800 97 0.256 0.294 to 0.206
800–1,200 50 0.296 0.626 to 0.034The AAQ-mediated PLR in opn4/ rd1/rd1mice could be trig-
gered by photopic irradiance levels normally encountered during
daytime, but the PLR threshold was 2 to 3 log units higher than
the normal PLR in wild-typemice (Figure 5B). The AAQ-mediated
PLR was slower than in wild-type mice (see Movie S1), and AAQ
induced some basal pupillary constriction in darkness. Nonethe-
less, these results show that light responses in AAQ-treated
retina can drive brain circuits, leading to a behavioral response
that is absent from untreated blind animals.
We next tested whether locomotory light-avoidance behavior
(Johnson et al., 2010; Kandel et al., 1987) could be restored in
blind opn4/ rd1/rd1 mice treated with a unilateral intravitreal
injection of AAQ. We placed a mouse into a narrow cylindrical
transparent tube and recorded behavior with an infrared video
camera (Figure 6A). An automated image analysis system was
used to detect the mouse and measure how quickly it moved
away from the illuminated end of the tube, toward the center.
The latency to movement was significantly shorter in light than
in darkness in wild-type mice (n = 13, 26 trials, p < 0.01) but
not in opn4/ rd1/rd1 mice (n = 7, 14 trials), indicating light
avoidance in the wild-type mice but not in the mutant mice.
AAQ reinstated the light versus dark latency difference,
measured 2 hr after injection (n = 7, 14 trials, p < 0.02), indicating
restoration of light avoidance. At 24 hr after AAQ injection, there
was no difference in latency in light versus darkness, consistent
with dissipation of the AAQ. These results indicate that an active
light-avoidance behavior can be elicited by AAQ following
a single injection into the eye.
Wild-type mice exhibit a decrease in open-field locomotion in
response to light, which corresponds to a decrease in explor-
atory drive (Bourin and Hascoe¨t, 2003). In contrast, rd1 miceNeuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc. 275
Figure 4. Spectral and Illuminance Sensitivity of AAQ-Mediated Photocontrol of RGC Firing
(A) Spectral sensitivity of light-elicited suppression of RGC firing. Top: Light stimulation protocol. AAQ was first driven into its cis configuration with 380 nm light
(5 s), and various test wavelengths triggered photoisomerization to the trans configuration. Bottom: PI values reveal the effectiveness of different wavelengths in
suppressing RGC firing (n = 5 retinas). Error bars represent mean ± SEM.
(B) Spectral sensitivity of light-elicited activation of RGC firing. Top: Light stimulation protocol. AAQ was first driven into its trans configuration with 500 nm light
(15 s). After an additional dark period (45 s) various test wavelengths triggered photoisomerization to the cis configuration. Bottom: PI values reveal the effec-
tiveness of different wavelengths in stimulating RGC firing (n = 5 retinas). For (A) and (B), the PI was measured over the first 1 s after applying the test wavelength.
Error bars represent mean ± SEM.
(C) Stimulation of RGC firing in an AAQ-treated retina with white light. Top: Raster plot of spiking from RGCs. Bottom: Average RGC firing rate.
(D) Box plot representation of increased firing rate in white light versus 500 nm. White light significantly increases peak firing rate (p < 0.05, Mann-Whitney test,
n = 5). Whiskers denote 1.5 times the interquartile range from the 25th and 75th percentile.
(E) Light intensity-response relationship for AAQ-treated rd1 mouse retinas exposed to different intensities of 380 nm light. Minimum light intensity needed for
photoswitching is 2.6 3 1015 photons/cm2/s. Error bars represent mean ± SEM.
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illumination (Lin et al., 2008). In order to determine if AAQ can
support light modulated exploratory behavior in rd1 mice, we
carried out open field experiments. We placed a mouse into276 Neuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc.a circular test chamber and monitored movement during 5 min
in darkness followed by 5 min in 380 nm light. Figures 7A and
7B show an example of the effect of AAQ on one rd1 mouse
(see also Movies S2 and S3). Before AAQ, light had no effectFigure 5. AAQ Restores the Pupillary Light Reflex
in Mice Lacking All Retinal Photoreceptors
(A) Pupillary light responses to 5.5 3 104 mW/m2 white
light in opn4/ rd/rdmice, before (left) and 3 hr after (right)
intravitreal injection of AAQ (1 ml of 80 mM in DMSO). Dark
images taken 5 s before light stimulus; light images
represent maximal pupillary constriction during 30 s light
exposure. Images were taken with an infrared-sensitive
camera under infrared illumination.
(B) Irradiance-dependence of pupillary light responses to
white light. Irradiance response for wild-type mice (plotted
as mean ± STD, n = 5) (A) and four opn4/ rd/rd mice
injected with AAQ (plotted individually: CB;D). Data
were fitted with a three parameter Hill equation.
See also Figure S4 and Movie S1.
Figure 6. AAQ Restores Active Light Avoidance Behavior in Mice
Lacking All Retinal Photoreceptors
(A) Schematic diagram of the locomotory light-avoidance test chamber.
(B) Restoration of light avoidance behavior in opn4/ rd/rd mice following
AAQ injection. Bars represent mean latency of movement from the ‘‘East’’ to
the ‘‘Center’’ third of the tube (plotted as ± STD).
Neuron
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(Figure 7B). After AAQ, light caused an almost immediate
decrease in exploratory behavior, quantified as diminished
distance traveled. Average data from eight rd1 mice showed
no light versus dark difference in movement before AAQ (Fig-
ure 7C). However, after AAQ, there was a decrease in movement
that occurred within 30 s of light onset. This decrease was sus-
tained throughout the illumination period. Before AAQ, there was
no statistically significantly change in the speed of locomotion in
light as compared to darkness (Figure 7D), but after AAQ injec-
tion, light caused a significant 40% slowing of locomotion.
Sham injections with vehicle alone elicited no significant change
in light modulated behavior (n = 4, p > 0.6). Further analysis of the
eight mice showed that seven of them exhibited significant light-
evoked slowing of locomotion after AAQ injection (Figure 7E).
After termination of the behavioral test, mice were sacrificed
and retinas were placed on the MEA for electrophysiologicalanalysis. In five cases, we successfully obtainedMEA recordings
and were able to directly compare the AAQ-mediated photosen-
sitization of the retina ex vivo with the behavioral responses
in vivo. The one mouse that failed to exhibit light-modulated
behavior (mouse A in Figures 7E and 7F) also failed to exhibit
light-sensitive retinal responses. For all of the other four mice,
light-elicited behavior corresponded with a light-elicited change
in firing rate.
Rd1 mice possess ipRGCs, which should respond to the light
used in this behavioral test. However, previous studies (Lin et al.,
2008) show that ipRGCs do not mediate short-term light-elicited
changes in exploratory behavior. Moreover, in our open field
experiments, mice exhibited no light-modulated behavior prior
to AAQ injections, confirming that alone, the ipRGCs are not
sufficient to evoke this behavior.
DISCUSSION
The ultimate goal of vision restoration research is to recreate as
closely as possible the activity of the entire population of RGCs in
response to a natural visual scene. Since only a small fraction of
RGCs are intrisically light-sensitive (Ecker et al., 2010; Panda
et al., 2003), photosensitivity must be conferred artificially by
directly or indirectly making the neurons sensitive to light. Ideally,
the kinetics and absolute sensitivity to light should be equivalent
to natural RGC responses. The healthy retina has a remarkably
broad operating range owing to light-adaptation mechanisms,
so the artificial system should include gain adjustment and range
extension capabilities. Ideally, the system would replicate
normal encoding of contrast and color and highlight movement,
with certain RGCs being directionally selective. All of this should
be accomplished with a minimally invasive and safe technology.
To date, no restorative technology is close to meeting these
criteria, but new developments are providing reason for
optimism.
Broadly, three approaches have been suggested for restoring
visual function to the eye in the absence of rods and cones:
optoelectronic engineering with retinal chip prosthetics; genetic
engineering with viral-mediated delivery of optogenetic tools;
and cellular engineering, with rod or cone progenitors differenti-
ated from stem cells in vitro. We now describe a fourth approach:
photochemical engineering with a small molecule photoswitch.
The following functional considerations suggest that the
photoswitch approach compares favorably with other methods
for restoringvisual functionandoffers somepractical advantages.
Kinetics
AAQ-mediated retinal light responses are rapid. MEA recordings
show that the median response latency of RGC spiking is 45 ms
in the AAQ-treated rd1 mouse retina, compared to 50 ms
(Farrow and Masland, 2011) to several hundred ms (Carcieri
et al., 2003) for photopic light responses from RGCs in wild-
type retina. Retinal chips electrically stimulate RGCs directly,
and therefore can elicit spikes with latencies of several millisec-
onds. For optogenetic tools, depending onwhich retinal cell type
expresses the tool, the response latency of RGCs ranges from
several milliseconds to 150 ms (Bi et al., 2006; Busskamp
et al., 2010; Lagali et al., 2008). Stem cell-based therapies wouldNeuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc. 277
Figure 7. AAQ Restores Light-Modulated
Locomotor Behavior in an Open-Field Test
(A) Paths traveled by an rd1 mouse before and
after injection with AAQ in darkness and with
380 nm illumination.
(B) Cumulative distance traveled by the mouse in
darkness and in 380 nm light, before and after
AAQ.
(C) Average cumulative distance traveled of all
mice in darkness and 380 nm light, before and after
AAQ. Closed squares represent time spent in
darkness while open squares represent time spent
in 380 nm light. (mean ± SEM, n = 8).
(D) Mean locomotory velocity in light normalized to
basal velocity in darkness. Velocity decreases
significantly in light (n = 8, p < 0.0006).
(E) Light evoked change in the velocity of each of
the eight mice before and after AAQ. The red line
shows the mean light evoked change before and
after AAQ.
(F) Light-induced behavior is correlated with the
light-induced change in firing rate. Data were from
the five mice for which both in vivo behavioral
measurement and ex vivo retinal MEA recordings
were obtained (as labeled a–e in panel E). The
light-induced percent change in firing rate was
calculated from the aggregate light response for all
units recorded with the MEA upon switching from
darkness to 380 nm light. The light-induced
behavior represents percent change in velocity
upon switching from darkness to 380 nm light.
See also Movies S2 and S3.
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ated rods and cones have full function.
Sensitivity
MEA recordings in vitro and PLR measurements in vivo indicate
that the AAQ-treated rd1 mouse retina responds under bright
photopic conditions, comparable to levels achieved in natural
outdoor illumination. This is similar to light sensitivity conferred
onto RGCs by optogenetic tools (Bi et al., 2006; Thyagarajan
et al., 2010). Exogenous expression of NpHR in cone remnants
can result in higher light sensitivity (Busskamp et al., 2010).
However, it is unclear whether many patients with advanced
RP have sufficient cone remnants to allow this to be a broadly
applicable approach (Milam et al., 1998). High sensitivity can
also be conferred by exogenously expressing melanopsin in
RGCs that are not normally light-sensitive (Lin et al., 2008), but
the responses are variable and slow (on the order of seconds).
Stem cell-based therapies in theory might recapitulate the
wild-type sensitivity of rods and cones. However, the human
retina normally contains >100,000,000 rods and cones, and278 Neuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc.whether a significant fraction can be
restored with stem cells remains unclear.
Spatial Resolution and Extent
of Retinal Functional Restoration
AAQ-mediated retinal responses have
a high spatial resolution. Our spot illumi-nation experiments places a 100 mm radius upper limit on the
AAQ-mediated receptive field size. Amacrine cells, which
predominate in driving RGC responses, can project over several
hundred mm, but mutual inhibition between these cells presum-
ably spatially constrains RGC responses to a smaller area.
Because AAQ is a diffusible small molecule, in principle it should
reach the entire retina and confer light sensitivity on all RGCs. In
practice, we observed robust light responses in almost all RGCs
when AAQ was applied in vitro, but intravitreal injections in vivo
were less effective, with only 25%–36% of injections resulting
in behavioral responses to light. Drug delivery via intravitreal
injections in mice can be unreliable because of the very small
vitreal volume (20 ml), which is 250-fold less than the vitreal
volume of the human eye (5.5 ml). Further experiments using
animals with larger vitreal volumes are needed to better test
and optimize the effectiveness of intravitreal AAQ administration.
In contrast to the relatively high spatial resolution that could be
conferred by AAQ, the spatial resolution of a retinal chip is limited
by the relatively large size of the stimulating electrodes and the
spread of current emanating from each electrode. While the
Neuron
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chips have 16–64 electrodes spaced 100–200 mm apart (Winter
et al., 2007). Chips with electrodes more densely packed exhibit
crosstalk between electrodes, limiting their effectiveness. At
present, the highest resolution that could be provided by retinal
chip stimulation is several orders of magnitude lower than the
theoretical limits imposed by RGC density in the macula, the
region crucial for high-acuity vision. The area of RGC stimulation
is limited by the physical size of the chip implant, which typically
covers only the central 20 degrees of vision in the macula
(Chader et al., 2009). Larger chips are possible, but there are
challenges in power delivery and achieving stable adherence
to the retina.
Similar to photoswitches, the spatial resolution conferred by
optogenetic tools is defined by the size of the cell type targeted
for expressing a given light-activated protein. In principle, the
smaller the cell type and the more densely they are packed
together, the higher the spatial resolution. In practice, viral trans-
duction with current vectors has resulted in expression of opto-
genetic tools in a minority of targeted cells (e.g., 5% of bipolar
cells in mice [Lagali et al., 2008] and 5%–10% of RGCs in
marmosets [Ivanova et al., 2010]), but it is possible that new viral
vectors will be developed that improve transduction efficiency
(Vandenberghe et al., 2011). Viral transduction of NpHR has
resulted in more efficient transduction (50%–75%) of remnant
cones in blind mice (Busskamp et al., 2010), but this approach
is only appropriate for the few patients thought to possess
remnant cones. Viral transduction of cones requires subretinal
injection, which involves local detachment of a portion of the
retina from the underlying retinal pigment epithelium. Effective
viral gene transfer is limited to the detached area (Hauswirth
et al., 2008).
Stem cell approaches offer the potential for greater spatial
resolution, but this is dependent on having a high density of
differentiated photoreceptor cells that form functional and
anatomically correct synapses with appropriate retinal neuron
partners, and at present, only a very low density of cells has
been achieved (Lamba et al., 2009).
ON and OFF Retinal Output Channels
Optogenetic tools have the advantage of being genetically-
targetable to particular types of neurons to generate the appro-
priate stimulation or inhibition of firing, for example to ON- or
OFF-RGCs (Busskamp et al., 2010; Lagali et al., 2008). More-
over, ChR2 and NpHR can be co-expressed in the same RGC
and trafficked to different compartments to restore antagonistic
center-surround responses (Greenberg et al., 2011). In contrast,
all RGCs in AAQ-treated retina respond with the same polarity
light response. While this pattern of responsiveness is different
than the normal retina, it may not preclude a useful visual expe-
rience. Behavioral studies in primates demonstrate that the
selective pharmacological blockade of ON neurons does not
severely impair recognition of shapes or detection of light decre-
ments (Schiller et al., 1986). Moreover, in RP patients, electronic
retinal prosthetics can restore shape recognition, even though
the devices stimulate ON- and OFF-RGCs indiscriminately
(Sekirnjak et al., 2009). Hence, while two channels of visual
information flow are important for normal vision, simultaneousactivation of ON- and OFF-pathways is sufficient for visual
perception. AAQ treatment enables RGCs surrounding an illumi-
nated area to respond with the opposite polarity to those in the
center. Since all RGCs respond with the same polarity light
response to full-field illumination (Figure 1A), the opposite center
versus surround responses to spot illumination suggests that
inhibitory neurons that project laterally invert the sign of the
response. It seems likely that the opposite center versus
surround responsewould enhance perception of spatial contrast
and facilitate edge detection in downstream visual regions of the
brain. But ultimately, the evaluation of the quality of images
produced by photoswitch activation of retinal cells will require
study in primates or human patients.
Spectral Sensitivity
In AAQ-treated retinas, RGCs respond most strongly to short
wavelength light, consistent with the photochemical properties
of the molecule (Fortin et al., 2008). Although 380 nm light is
optimal for enhancing firing frequency, longer wavelengths (up
to 500 nm) can still generate excitatory light responses, reflecting
the spectral range of trans to cis azobenzene photoisomeriza-
tion. This is important, because unlike in the mouse, the human
lens minimally transmits 380 nm light (Kessel et al., 2010).
Newly-developed red-shifted azobenzene derivatives allow K+
channel regulation with even longer wavelengths of light and
chemical modification of the azobenzene moiety results in
compounds with improved quantum efficiency (Mourot et al.,
2011). Ideally, second-generation AAQ derivatives would enable
photostimulation of the retina with intensities and wavelengths
experienced during normal photopic vision. Alternatively,
a head-mounted optoelectronic visual aid (Degenaar et al.,
2009) designed to intensify and transform the palette of visual
scenes to a blue-shifted wavelength could enhance the effec-
tiveness of AAQ and related agents. Such a device might also
allow switching of individual RGCs ON and OFF by rapid modu-
lation of shorter- and longer-wavelength light.
Except for some of the optogenetic tools, the other vision
restoration methods pose no particular spectral challenges.
NpHR and ChR2 respond optimally to 580 and 470 nm light,
respectively (Nagel et al., 2003; Zhang et al., 2007), but newly
discovered red-shifted homologs (Govorunova et al., 2011)
expand the toolkit for potential use for photosensitizing retinal
neurons. Since they are driven by images captured by an
external camera, retinal chip prosthetics can be engineered to
operate over the entire visual spectrum. Similarly, assuming
stem cell-derived photoreceptors express the full complement
of cone opsins, these should be responsive to a broad range
of wavelengths.
Invasiveness, Safety, and Reversibility
The phototswitch approach has the advantage of being relatively
noninvasive and readily reversible. We envision photoswitch
molecules being administered therapeutically by intravitreal
injection, a safe and frequent procedure for treating macular
degeneration with anti-vasoproliferative agents. Because AAQ
photosensitization dissipates within 24 hr, it may be possible
to titrate the most effective dose with repeated intravitreal injec-
tions. The reversibility of AAQ will allow for ‘‘upgrades’’ as newerNeuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc. 279
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kinetic properties. Longer-term therapy would require an
extended release formulation. We estimate that a several month
supply of AAQ could be packaged into an intravitreal device like
those currently used for long-term steroid treatment of ocular
inflammation (London et al., 2011).
In contrast, retinal chip prosthetics require invasive intraocular
surgery. Optogenetic treatment of remnant cones and stem cell
therapy both require subretinal injection, a risky procedure that
begins with iatrogenic retinal detachment, which could further
damage the retina. These three approaches are essentially irre-
versible. Should they produce undesired effects (such as chronic
photophobia or disturbing visual sensations) there is no ready
means for reversal of either stem cell implantation or gene
therapy, and removal of chip prosthetics would require addi-
tional significant surgery.
Both retinal chip prosthetics and human gene replacement
therapy have received investigational new device/drug status
and have been tested in human patients under research proto-
cols (Ahuja et al., 2011; Benav et al., 2010) without significant
toxicity. However, microbial optogenetic tools would require
trans-species gene therapy, which is unprecedented. Viral
gene expression in the eye can elicit late-onset inflammation,
indicating an immune reaction (Beltran et al., 2010). Because
the unitary conductance of ChR2 and NpHR is quite small
(Feldbauer et al., 2009; Sjulson and Miesenbo¨ck, 2008; Zhang
et al., 2007), photosensitivity requires very high levels of exoge-
nous expression, raising concerns about an immune response to
the microbially-derived protein or cytotoxicity. While long-term
safety of AAQ or similar compounds will require toxicology
studies, to date, we have not seen acute toxicity of AAQ on
neural function in vitro (Fortin et al., 2008) or in vivo (Figure S2).
The pathway for evaluating photoswitch compounds for toxicity
is straightforward and will mirror those that have been followed
for other approved, intravitreal agents.
Finally, in addition to its potential clinical use, AAQ has utility as
a scientific tool for understanding normal retinal function and
development. Using AAQ, the firing activity of single cells or
small regions of the retina can be controlled with high temporal
and spatial resolution. This may be useful for better under-
standing information processing by the retina and for studying
developmental plasticity in animals before rods and cones are
functional (Huberman et al., 2008). AAQ-mediated photocontrol
of retinal neurons also provides a unique way to investigate
circuit remodeling after the rods and cones have degenerated
in mouse models of RP (Marc et al., 2003).EXPERIMENTAL PROCEDURES
Animals
Wild-type mice (C57BL/6J strain, Jackson Laboratories) and homozygous rd1
mice (C3H/HeJ strain, Charles River Laboratories) >3 months old were used
for the experiments. All animal use procedures were approved by the UC
Berkeley or University of Washington Institutional Animal Care and Use
Committee (see Supplemental Experimental Procedures).
Electrophysiology and Pharmacology
Mouse retinaswere dissected and kept in physiological saline at 36C contain-
ing (in mM) 119 NaCl, 2.5 KCl, 1 KH2PO4, 1.3 MgCl2, 2.5 CaCl2, 26.2 NaHCO3,280 Neuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc.and 20 D-glucose, aerated with 95% O2/5% CO2. For extracellular recording,
the retina was placed ganglion cell layer down onto a multielectrode array
system (model number MEA 1060-2-BC, Multi-Channel Systems).
The MEA electrodes were 30 mm in diameter and arranged on an 83 8 rect-
angular grid. Extracellular spikes were high-pass filtered at 200 Hz and digi-
tized at 20 kHz. A spike threshold of 4SD was set for each channel. Typically,
each electrode recorded spikes from one to three RGCs. Principal component
analysis of spike waveforms was used for sorting spikes generated by indi-
vidual cells (Offline Sorter; Plexon). Only cells with interspike intervals of
<1 ms were included in the analysis.
Borosilicate glass electrodes of 6–11 MU were used for whole-cell voltage-
clamp recordings. Current records were low-pass filtered at 2 kHz. For
measuring voltage-gated K+ currents, electrodes contained (in mM) 98.3 K+
gluconate, 1.7 KCl, 0.6 EGTA, 5 MgCl2, 40 HEPES, 2 ATP-Na, and 0.3 GTP-
Na (pH = 7.25). For recording glutamatergic EPSCs, electrodes contained
(in mM) 125 Cs+ sulfate, 10 TEA-Cl, 5 EGTA, 0.85 MgCl2, 10 HEPES,
2 QX-314, and 4 ATP-Na2 (pH = 7.25). Neurotransmitter receptor antagonists
were used to evaluate synaptic contributions of different retinal neurons to
RGC light responses (see Supplemental Experimental Procedures).
Light Stimulation
In MEA recordings, we used a 100 Wmercury arc lamp filtered through 380 or
500 nm narrow-pass filters (Chroma, Inc.) and switched wavelengths with an
electronically-controlled shutter and filter wheel (SmartShutter, Sutter Instru-
ments). Unless otherwise indicated, the standard incident light intensity at
the retina was 13.4 mW/cm2 (2.56 3 1016 photons/cm2/s) for 380 nm and
11.0 mW/cm2 (2.77 3 1016 photons/cm2/s) for 500 nm.
PLR Measurement
Micewere sedatedwith an intraperitoneal injection of ketamine (6.7mg/ml) and
xylazine (0.45 mg/ml) in saline. A glass micropipette was inserted through the
sclera into the vitreous cavity to inject a 1 ml bolus of AAQ (80 mM in a saline
solution containing 40% DMSO).
Videos of pupillary light responses of mice were recorded before and 3 hr
after AAQ injection. White light was derived from halogen dissecting lamp,
and intensity was controlled with neutral density filters. Animals were dark-
adapted for at least 20min prior to testing. An infrared (IR) illuminator and video
camera (focused 15 cm from the objective) was used to measure pupil dilation,
as described (Van Gelder, 2005).
Locomotory Light Avoidance
Wild-type or opn4/ rd/rdmice injected with 80 mM AAQ were dark-adapted
and placed into a transparent tube. The tube was illuminated with IR light and
mouse movement was recorded with an IR video camera and stored for offline
analysis. During testing, the face of the mouse was illuminated with 385 nm
light (log irradiance 15.7) and at 5 s intervals flashes of 480 nm light (log irradi-
ance 15.2) were superimposed. For each mouse, we recorded position in the
tube preinjection, and 2 hr and 24 hr postinjection. Analysis was conducted
with automated image-analysis software.
Open-Field Test
Rd1 mice were placed in a 190 mm 3 100 mm circular UV-transparent
chamber. The chamber was surrounded by six panels of 380 nm LEDs
(Roithner Laserteknik), providing uniform illumination with a light intensity
of 7 mW/cm2.
Themice were dark-adapted in their cages for 1 hr prior to each experiment.
The mice were placed in the experimental chamber and allowed to acclimate
for 5 min. The behavior was then recorded using an IR sensitive video camera
(Logitech C310) for 5 min in darkness under IR illumination. After 5 min, the
chamber was illuminated by the 380 nm LEDs, and behavior was monitored
for an additional 5 min. The apparatus was cleaned and thoroughly dried prior
to each experiment.
After the open-field test, each mouse was given an intravitreal injection of
AAQ (20 mM AAQ, 9:1 saline: DMSO) and were allowed to recover for 6 hr
on a heating pad with open access to food and water in their cage located
in the dark room followed by a second round of behavioral testing. The videos
were analyzed utilizing motion tracking video analysis software (Tracker) in
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throughout the test, and the total distance traveled.
Data Analysis and Statistics
Light-elicited changes in firing rate during test flashes were normalized with
respect to initial firing rate and expressed as a PI, defined as follows: PI =
(test firing rate – initial firing rate) / (test firing rate + initial firing rate).
Relative pupillary light responses were calculated as 1  (pupil area
minimum during thirty seconds of the light stimulus) / (pupil area minimum
during five seconds preceding the stimulus). Relative response data for wild-
type and opn4/ rd/rd mice were fitted with a three parameter Hill equation
(SigmaPlot, Systat Software, Inc.). Data are expressed asmean ± SEM, unless
otherwise indicated. The p values for open-field experiments were calculated
using the two tailed unpaired Students t test.
Latencies were calculated for every cell with a PI greater than 0.011, the
upper median confidence interval PI of our control experiments (n = 13 retinas;
n = 409 cells). For each cell, firing rate was averaged over the first two light
periods (dark and 380 nm light), with a 10 ms bin size. Basal firing rate was
calculated from theuppermedianconfidence interval in 500nm light.Response
latencywas then calculated as the timedifference between the onset of 380 nm
light and the first bin with a firing rate greater than the cell’s basal activity. The
median response latency was 45 ms (n = 10 retinas; n = 368 cells).
All statisticswereperformedwithMATLAB (Mathworks) algorithms.Distribu-
tionswere first tested for normality using the Shapiro-Wilk test. For non-normal
distributions, the Wilcoxon rank sum test was used for pairwise comparisons.
The 95% confidence intervals for medians were generated by resampling the
original distributions and applying the bias-corrected percentile method (Efron
and Tibshirani, 1986). Results with p < 0.05 were considered significant.
For all box plots, box limits represent the 25th and 75th percentile, respec-
tively. The red line represents themedian andwhiskers denote 1.5 times the in-
terquartile range from the limits of the box. Outliers are marked by red + signs.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, two tables, Supplemental
Experimental Procedures, and three movies and can be found with this article
online at http://dx.doi.org/10.1016/j.neuron.2012.05.022.
ACKNOWLEDGMENTS
We thank A. Anishchenko and J. Elstrott for helpful comments and discus-
sions; Trevor Lee, Andrew Noblet, R. Montpetit, T. Lamprecht, and X. Qiu for
technical and experimental assistance; and J. Flannery and K. Greenberg for
valuable suggestions. This work was supported by the National Eye Institute
(NEI), which provided research Grant EY018957 to R.H.K., Core Grant
P30 EY003176 to R.H.K., and Core Grant P30 EY001730 to R.V.G. This
work was also supported by Beckman Foundation for Macular Research
(R.H.K.) and a Research to Prevent Blindness award to Y.S. and R.V.G. and
an Ezell Fellowship to A.P. The NEI also funded the Nanomedicine Develop-
ment Center (PN2 EY018241), which supported this interdisciplinary project.
R.H.K. and D.T. are SAB members and consultants of Photoswitch Biosci-
ence, Inc., which is developing commercial uses for chemical photoswitches.
A.P., J.L., I.T., J.N., Y.S., T.H., I.D.K., andK.B. conducted the in vitro and in vivo
experiments. D.T. designed and synthesized chemical reagents. R.H.K. and
R.V.G. coordinated the research and wrote the manuscript. R.H.K. initiated
the research and supervised the program.
Accepted: April 30, 2012
Published: July 25, 2012
REFERENCES
Ahuja, A.K., Dorn, J.D., Caspi, A., McMahon, M.J., Dagnelie, G., Dacruz, L.,
Stanga, P., Humayun, M.S., and Greenberg, R.J.; Argus II Study Group.
(2011). Blind subjects implanted with the Argus II retinal prosthesis are able
to improve performance in a spatial-motor task. Br. J. Ophthalmol. 95,
539–543.Banghart, M.R., Mourot, A., Fortin, D.L., Yao, J.Z., Kramer, R.H., and Trauner,
D. (2009). Photochromic blockers of voltage-gated potassium channels.
Angew. Chem. Int. Ed. Engl. 48, 9097–9101.
Beltran, W.A., Boye, S.L., Boye, S.E., Chiodo, V.A., Lewin, A.S., Hauswirth,
W.W., and Aguirre, G.D. (2010). rAAV2/5 gene-targeting to rods:dose-depen-
dent efficiency and complications associated with different promoters. Gene
Ther. 17, 1162–1174.
Benav, H., Bartz-Schmidt, K.U., Besch, D., Bruckmann, A., Gekeler, F.,
Greppmaier, U., Harscher, A., Kibbel, S., Kusnyerik, A., Peters, T., et al.
(2010). Restoration of useful vision up to letter recognition capabilities using
subretinal microphotodiodes. In Engineering in Medicine and Biology
Society (EMBC), 2010 Annual International Conference of the IEEE, pp.
5919–5922.
Bi, A., Cui, J., Ma, Y.P., Olshevskaya, E., Pu, M., Dizhoor, A.M., and Pan, Z.H.
(2006). Ectopic expression of a microbial-type rhodopsin restores visual
responses in mice with photoreceptor degeneration. Neuron 50, 23–33.
Bourin, M., and Hascoe¨t, M. (2003). The mouse light/dark box test. Eur. J.
Pharmacol. 463, 55–65.
Busskamp, V., Duebel, J., Balya, D., Fradot, M., Viney, T.J., Siegert, S.,
Groner, A.C., Cabuy, E., Forster, V., Seeliger, M., et al. (2010). Genetic reacti-
vation of cone photoreceptors restores visual responses in retinitis pigmen-
tosa. Science 329, 413–417.
Caporale, N., Kolstad, K.D., Lee, T., Tochitsky, I., Dalkara, D., Trauner, D.,
Kramer, R., Dan, Y., Isacoff, E.Y., and Flannery, J.G. (2011). LiGluR restores
visual responses in rodent models of inherited blindness. Mol. Ther. 19,
1212–1219.
Carcieri, S.M., Jacobs, A.L., and Nirenberg, S. (2003). Classification of retinal
ganglion cells: a statistical approach. J. Neurophysiol. 90, 1704–1713.
Chader, G.J., Weiland, J., and Humayun, M.S. (2009). Artificial vision: needs,
functioning, and testing of a retinal electronic prosthesis. Prog. Brain Res.
175, 317–332.
Chaudhry, G.R., Fecek, C., Lai, M.M., Wu, W.C., Chang, M., Vasquez, A.,
Pasierb, M., and Trese, M.T. (2009). Fate of embryonic stem cell derivatives
implanted into the vitreous of a slow retinal degenerative mouse model.
Stem Cells Dev. 18, 247–258.
Degenaar, P., Grossman, N., Memon, M.A., Burrone, J., Dawson, M.,
Drakakis, E., Neil, M., and Nikolic, K. (2009). Optobionic vision—a new genet-
ically enhanced light on retinal prosthesis. J. Neural Eng. 6, 035007.
Ecker, J.L., Dumitrescu, O.N., Wong, K.Y., Alam, N.M., Chen, S.-K., LeGates,
T., Renna, J.M., Prusky, G.T., Berson, D.M., and Hattar, S. (2010). Melanopsin-
expressing retinal ganglion-cell photoreceptors: cellular diversity and role in
pattern vision. Neuron 67, 49–60.
Efron, B., and Tibshirani, R. (1986). Bootstrap methods for standard errors,
confidence intervals, and other measures of statistical accuracy. Stat. Sci. 1,
54–75.
Farrow, K., and Masland, R.H. (2011). Physiological clustering of visual
channels in the mouse retina. J. Neurophysiol. 105, 1516–1530.
Feldbauer, K., Zimmermann, D., Pintschovius, V., Spitz, J., Bamann, C., and
Bamberg, E. (2009). Channelrhodopsin-2 is a leaky proton pump. Proc. Natl.
Acad. Sci. USA 106, 12317–12322.
Fortin, D.L., Banghart, M.R., Dunn, T.W., Borges, K., Wagenaar, D.A., Gaudry,
Q., Karakossian, M.H., Otis, T.S., Kristan, W.B., Trauner, D., and Kramer, R.H.
(2008). Photochemical control of endogenous ion channels and cellular excit-
ability. Nat. Methods 5, 331–338.
Gerding, H., Benner, F.P., and Taneri, S. (2007). Experimental implantation of
epiretinal retina implants (EPI-RET) with an IOL-type receiver unit. J. Neural
Eng. 4, S38–S49.
Govorunova, E.G., Spudich, E.N., Lane, C.E., Sineshchekov, O.A., and
Spudich, J.L. (2011). New channelrhodopsin with a red-shifted spectrum
and rapid kinetics from Mesostigma viride. MBio 2, e00115–e11.
Greenberg, K.P., Pham, A., and Werblin, F.S. (2011). Differential targeting of
optical neuromodulators to ganglion cell soma and dendrites allows dynamic
control of center-surround antagonism. Neuron 69, 713–720.Neuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc. 281
Neuron
Restoration of Visual Responses in Blind MiceHattar, S., Liao, H.W., Takao, M., Berson, D.M., and Yau, K.W. (2002).
Melanopsin-containing retinal ganglion cells: architecture, projections, and
intrinsic photosensitivity. Science 295, 1065–1070.
Hauswirth, W.W., Aleman, T.S., Kaushal, S., Cideciyan, A.V., Schwartz, S.B.,
Wang, L.L., Conlon, T.J., Boye, S.L., Flotte, T.R., Byrne, B.J., and Jacobson,
S.G. (2008). Treatment of leber congenital amaurosis due to RPE65 mutations
by ocular subretinal injection of adeno-associated virus gene vector: short-
term results of a phase I trial. Hum. Gene Ther. 19, 979–990.
Huberman, A.D., Feller, M.B., and Chapman, B. (2008). Mechanisms under-
lying development of visual maps and receptive fields. Annu. Rev. Neurosci.
31, 479–509.
Humayun,M.S., Weiland, J.D., Fujii, G.Y., Greenberg, R., Williamson, R., Little,
J., Mech, B., Cimmarusti, V., Van Boemel, G., Dagnelie, G., and de Juan, E.
(2003). Visual perception in a blind subject with a chronic microelectronic
retinal prosthesis. Vision Res. 43, 2573–2581.
Ivanova, E., Hwang, G.S., Pan, Z.H., and Troilo, D. (2010). Evaluation of
AAV-mediated expression of Chop2-GFP in the marmoset retina. Invest.
Ophthalmol. Vis. Sci. 51, 5288–5296.
Jime´nez, A.J., Garcı´a-Ferna´ndez, J.M., Gonza´lez, B., and Foster, R.G. (1996).
The spatio-temporal pattern of photoreceptor degeneration in the aged rd/rd
mouse retina. Cell Tissue Res. 284, 193–202.
Johnson, J., Wu, V., Donovan, M., Majumdar, S., Renterı´a, R.C., Porco, T.,
Van Gelder, R.N., and Copenhagen, D.R. (2010). Melanopsin-dependent light
avoidance in neonatal mice. Proc. Natl. Acad. Sci. USA 107, 17374–17378.
Kandel, G., Bedell, H., Walker, R., and Wolf, B. (1987). Negative phototaxis in
pigmented, albinotic and RCS rat pupsmeasured with a new technique. Vision
Sci. 1, 357–366.
Kessel, L., Lundeman, J.H., Herbst, K., Andersen, T.V., and Larsen, M. (2010).
Age-related changes in the transmission properties of the human lens and their
relevance to circadian entrainment. J. Cataract Refract. Surg. 36, 308–312.
Lagali, P.S., Balya, D., Awatramani, G.B., Mu¨nch, T.A., Kim, D.S., Busskamp,
V., Cepko, C.L., and Roska, B. (2008). Light-activated channels targeted to ON
bipolar cells restore visual function in retinal degeneration. Nat. Neurosci. 11,
667–675.
Lamba, D.A., Gust, J., and Reh, T.A. (2009). Transplantation of human embry-
onic stem cell-derived photoreceptors restores some visual function in Crx-
deficient mice. Cell Stem Cell 4, 73–79.
Lamba, D.A., Karl, M.O., Ware, C.B., and Reh, T.A. (2006). Efficient generation
of retinal progenitor cells from human embryonic stem cells. Proc. Natl. Acad.
Sci. USA 103, 12769–12774.
Lin, B., Koizumi, A., Tanaka, N., Panda, S., and Masland, R.H. (2008).
Restoration of visual function in retinal degeneration mice by ectopic expres-
sion of melanopsin. Proc. Natl. Acad. Sci. USA 105, 16009–16014.
London, N.J., Chiang, A., and Haller, J.A. (2011). The dexamethasone drug
delivery system: indications and evidence. Adv. Ther. 28, 351–366.
Marc, R.E., Jones, B.W., Watt, C.B., and Strettoi, E. (2003). Neural remodeling
in retinal degeneration. Prog. Retin. Eye Res. 22, 607–655.
Meister, M., Pine, J., and Baylor, D.A. (1994). Multi-neuronal signals from the
retina: acquisition and analysis. J. Neurosci. Methods 51, 95–106.
Milam, A.H., Li, Z.Y., and Fariss, R.N. (1998). Histopathology of the human
retina in retinitis pigmentosa. Prog. Retin. Eye Res. 17, 175–205.
Mourot, A., Kienzler, M.A., Banghart, M.R., Fehrentz, T., Huber, F.M.E., Stein,
M., Kramer, R.H., and Trauner, D. (2011). Tuning photochromic ion channel
blockers. ACS Chemical Neuroscience, in press.282 Neuron 75, 271–282, July 26, 2012 ª2012 Elsevier Inc.Nagel, G., Szellas, T., Huhn, W., Kateriya, S., Adeishvili, N., Berthold, P., Ollig,
D., Hegemann, P., and Bamberg, E. (2003). Channelrhodopsin-2, a directly
light-gated cation-selective membrane channel. Proc. Natl. Acad. Sci. USA
100, 13940–13945.
Panda, S., Provencio, I., Tu, D.C., Pires, S.S., Rollag, M.D., Castrucci, A.M.,
Pletcher, M.T., Sato, T.K., Wiltshire, T., Andahazy, M., et al. (2003).
Melanopsin is required for non-image-forming photic responses in blind
mice. Science 301, 525–527.
Punzo, C., and Cepko, C. (2007). Cellular responses to photoreceptor death in
the rd1 mouse model of retinal degeneration. Invest. Ophthalmol. Vis. Sci. 48,
849–857.
Sancho-Pelluz, J., Arango-Gonzalez, B., Kustermann, S., Romero, F.J.,
van Veen, T., Zrenner, E., Ekstro¨m, P., and Paquet-Durand, F. (2008).
Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol.
Neurobiol. 38, 253–269.
Schiller, P.H., Sandell, J.H., andMaunsell, J.H. (1986). Functions of theONand
OFF channels of the visual system. Nature 322, 824–825.
Sekirnjak, C., Hulse, C., Jepson, L.H., Hottowy, P., Sher, A., Dabrowski, W.,
Litke, A.M., and Chichilnisky, E.J. (2009). Loss of responses to visual but not
electrical stimulation in ganglion cells of rats with severe photoreceptor
degeneration. J. Neurophysiol. 102, 3260–3269.
Shire, D.B., Kelly, S.K., Chen, J., Doyle, P., Gingerich, M.D., Cogan, S.F.,
Drohan, W.A., Mendoza, O., Theogarajan, L., Wyatt, J.L., and Rizzo, J.F.
(2009). Development and implantation of a minimally invasive wireless subre-
tinal neurostimulator. IEEE Trans. Biomed. Eng. 56, 2502–2511.
Sjulson, L., and Miesenbo¨ck, G. (2008). Photocontrol of neural activity:
biophysical mechanisms and performance in vivo. Chem. Rev. 108, 1588–
1602.
Strettoi, E., andPignatelli, V. (2000).Modifications of retinal neurons in amouse
model of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 97, 11020–11025.
Thyagarajan, S., van Wyk, M., Lehmann, K., Lo¨wel, S., Feng, G., and Wa¨ssle,
H. (2010). Visual function in mice with photoreceptor degeneration and trans-
genic expression of channelrhodopsin 2 in ganglion cells. J. Neurosci. 30,
8745–8758.
Tomita, H., Sugano, E., Isago, H., Hiroi, T., Wang, Z., Ohta, E., and Tamai, M.
(2010). Channelrhodopsin-2 gene transduced into retinal ganglion cells
restores functional vision in genetically blind rats. Exp. Eye Res. 90, 429–436.
Van Gelder, R.N. (2005). Nonvisual ocular photoreception in the mammal.
Methods Enzymol. 393, 746–755.
Vandenberghe, L.H., Bell, P., Maguire, A.M., Cearley, C.N., Xiao, R., Calcedo,
R., Wang, L., Castle, M.J., Maguire, A.C., Grant, R., et al. (2011). Dosage
thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey. Sci.
Transl. Med. 3, 88ra54.
Winter, J.O., Cogan, S.F., and Rizzo, J.F., 3rd. (2007). Retinal prostheses:
current challenges and future outlook. J. Biomater. Sci. Polym. Ed. 18,
1031–1055.
Yanai, D., Weiland, J.D., Mahadevappa, M., Greenberg, R.J., Fine, I., and
Humayun, M.S. (2007). Visual performance using a retinal prosthesis in three
subjects with retinitis pigmentosa. Am. J. Ophthalmol. 143, 820–827.
Zhang, F., Wang, L.P., Brauner, M., Liewald, J.F., Kay, K., Watzke, N., Wood,
P.G., Bamberg, E., Nagel, G., Gottschalk, A., and Deisseroth, K. (2007).
Multimodal fast optical interrogation of neural circuitry. Nature 446, 633–639.
